Dr. Stephen Nicholls and Dr. C. Michael Gibson Discuss: Safety and Efficacy of Obicetrapib in Patients With Heterozygous Familial Hypercholesterolemia (BROOKLYN) November 18, 2024 Disclosures: TBD
Dr. Katherine R Tuttle and Dr. C. Michael Gibson Discuss: Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial November 18, 2024 Disclosures: TBD
Dr. Daniel R. Bensimhon and Dr. C. Michael Gibson Discuss: Novel Bumetanide Nasal Spray (BNS) Demonstrates Safety, Tolerability and Equivalent Efficacy Compared to Intravenous and Oral Bumetanide (RSQ-777-02) November 18, 2024 Disclosures: TBD
Firas Zahr and Dr. C Michael Gibson Discuss: CLASP IID 2 YearRCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation October 30, 2024 Disclosures: TBD
Ajay J. Kirtane and Dr. C Michael Gibson Discuss: ECLIPSEA Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation October 29, 2024 Disclosures: TBD
Alexander Van Rosendael and Dr. C Michael Gibson Discuss: CONFIRM-2Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry October 28, 2024 Disclosures: TBD
David Erlinge and Dr. C Michael Gibson Discuss: INFINITY-SWEDEHEART Complex PCI1-Year and Landmark 6–12 Month Clinical Outcomes Among Patients With Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent October 28, 2024 Disclosures: TBD
Philippe Genereux and Dr. C Michael Gibson Discuss: Early TAVRTranscatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial October 28, 2024 Disclosures: TBD
Dr. Siddharth Patel and Dr. C Michael Gibson Discuss: Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71 September 2, 2024 Disclosures: TBD
Dr. Holger Thiele and Dr. C Michael Gibson Discuss: Temporary mechanical circulatory support in infarct-related cardiogenic shock – An individual patient data meta-analysis of all randomized trials with 6-month follow-up September 2, 2024 Disclosures: TBD
